<html>
<head>PUBMED IDs for CD223</head>
<body bgcolor='#C5F0F2'><h1>CD223</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11527700/'>T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.</a> August 31  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11937541/'>Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).</a> April 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12421911/'>Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3.</a> November 8  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12547595/'>MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells.</a> January 28  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12547552/'>Drug-eluting stents in vascular intervention.</a> January 28  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12547545/'>Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.</a> January 28  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12547538/'>New insights into EBV-associated post-transplant lymphoproliferative disease.</a> January 28  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12672063/'>The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells.</a> April 3  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12775570/'>MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).</a> May 31  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14644131/'>LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination.</a> December 3  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15009174/'>Cloning of rat lymphocyte activation gene-3 (Lag3; CD223) cDNA and its mRNA expression in rat tissues.</a> March 11  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15009170/'>Endovascular thrombolytic treatment of extensive dural sinus thrombosis in a heterozygous carrier of prothrombin gene G20210A mutation.</a> March 11  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15557174/'>Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223).</a> November 24  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15885122/'>The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.</a> May 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16569347/'>Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine.</a> March 30  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16621192/'>A soluble LAG-3 protein as an immunopotentiator for therapeutic vaccines: Preclinical evaluation of IMP321.</a> April 20  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19050298/'>Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo.</a> December 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19631993/'>Molecular cloning and expression analysis of pig lymphocyte activation gene-3 (LAG-3; CD223).</a> April 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19631990/'>Association between genetic polymorphism of XRCC1 Arg194Trp and risk of schizophrenia.</a> October 30  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19834647/'>Soluble pig lymphocyte activation gene-3 (LAG-3; CD223) inhibits human-to-pig xenogeneic mixed lymphocyte reaction.</a> March 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19834624/'>The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.</a> March 13  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21352204/'>Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates.</a> June 15  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21441454/'>MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis.</a> July 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24180338/'>Lymphocyte activation gene-3 expression defines a discrete subset of HIV-specific CD8+ T cells that is associated with lower viral load.</a> January 27  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25108024/'>Trafficking of LAG-3 to the surface on activated T cells via its cytoplasmic domain and protein kinase C signaling.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25780040/'>The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects.</a> June 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25941596/'>Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity.</a> May 6  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28434981/'>Protein transport inhibitors downregulate the expression of LAG-3 on regulatory T cells.</a> April 25  2017<br></body></html>
